Secondary Surgery (secondary + surgery)

Distribution by Scientific Domains


Selected Abstracts


Noggin Inhibits Postoperative Resynostosis in Craniosynostotic Rabbits,

JOURNAL OF BONE AND MINERAL RESEARCH, Issue 7 2007
Gregory M Cooper PhD
Abstract Inhibition of bone formation after surgery to correct craniosynostosis would alleviate the need for secondary surgeries and decrease morbidity and mortality. This study used a single dose of Noggin protein to prevent resynostosis and improve postoperative outcomes in a rabbit model of craniosynostosis. Introduction: Craniosynostosis is defined as the premature fusion of one or more of the cranial sutures, which causes secondary deformations of the cranial vault, cranial base, and brain. Current surgical intervention involves extirpation of the fused suture to allow unrestricted brain growth. However, resynostosis of the extirpated regions often occurs. Several bone morphogenetic proteins (BMPs), well-described inducers of ossification, are involved in bone healing. This study tested the hypothesis that a postoperative treatment with Noggin, an extracellular BMP inhibitor, can inhibit resynostosis in a rabbit model of human familial nonsyndromic craniosynostosis. Materials and Methods: Thirty-one New Zealand white rabbits with bilateral coronal suture synostosis were divided into three groups: (1) suturectomy controls (n = 13); (2) suturectomy with BSA in a slow-resorbing collagen vehicle, (n = 8); and (3) suturectomy with Noggin in a slow-resorbing collagen vehicle (n = 10). At 10 days of age, a 3 × 15-mm coronal suturectomy was performed. The sites in groups 2 and 3 were immediately filled with BSA-loaded gel or Noggin-loaded gel, respectively. Serial 3D-CT scan reconstructions of the defects and standard radiographs were obtained at 10, 25, 42, and 84 days of age, and the sutures were harvested for histological analysis. Results: Radiographic analysis revealed that Noggin-treated animals had significantly greater coronal suture marker separation by 25 days and significantly greater craniofacial length at 84 days of age compared with controls. 3D-CT analysis revealed that Noggin treatment led to significantly greater defect areas through 84 days and to increased intracranial volumes at 84 days of age compared with other groups. Histological analysis supported CT data, showing that the untreated and BSA-treated groups had significant healing of the suturectomy site, whereas the Noggin-treated group had incomplete wound healing. Conclusions: These data support our hypothesis that inhibition of BMP activity using Noggin may prevent postoperative resynostosis in this rabbit model. These findings also suggest that Noggin therapy may have potential clinical use to prevent postoperative resynostosis in infants with craniosynostosis. [source]


The resistance of maxillofacial reconstruction plates to biofilm formation in vitro

THE LARYNGOSCOPE, Issue 11 2003
Brian E. Emery MD
Abstract Objectives/Hypothesis: Bacterial biofilms, bacteria surrounded by a protective glycocalyx, have been demonstrated on bioimplants placed within and outside of the head and neck region. The presence of the biofilm often makes decontamination of an infected implant impossible, requiring removal of the implant. Infections attributable to biofilm formation within the facial skeleton after reconstruction with implants may result in delayed union, fibrous union, malunion, nonunion, and malocclusion. These complications often require removal of the implant and secondary surgery. Although the incidence of infections necessitating implant removal is relatively low, the increased numbers of implants being placed make this a growing problem. Previous work in the authors laboratory has demonstrated a resistance to biofilm formation on different types of pressure-equalizing tubes. The hypothesis evaluated in the study is that such resistance to biofilm formation is due to the inability of bacteria to adhere to the tubes because of the material's smoothness or surface charge. Study Design: A controlled observational study. Methods: Scanning electron microscopy was used to evaluate the formation of biofilms in vitro for a common strain of Staphylococcus aureus on four implantable materials. The implantable materials included titanium and polylactide resorbable plates. Results: Consistent with the authors' prior findings, they were able to produce bacterial biofilm reliably on a silicone pressure equalizing tube but were unable to demonstrate biofilm formation on the titanium or resorbable implants. Conclusion: The absence of biofilm formation on these implants can best be explained by the surface charge or polarity properties of these materials. These findings are consistent with the relatively low incidence of infections among patients receiving these implants in maxillofacial applications. [source]


Assessment of Five Interleukins in Human Synovial Fluid as Possible Markers for Aseptic Loosening of Hip Arthroplasty

ARTIFICIAL ORGANS, Issue 7 2009
Alina Beraudi
Abstract One of the most important factors that seems to be involved in total hip replacement is periprosthetic osteolysis. As it is well documented that several interleukins (ILs) are triggered in periprosthetic osteolysis, this article investigates the role of five ILs in primary and replacement total hip arthroplasty, understanding if one of them can also predict hip implant loosening, secondary surgery, and prosthesis breakage. The levels of IL-1,, 1,, 6, 8, and 10 in synovial fluid were examined, using a high sensitivity enzyme-linked immunosorbent assay (ELISA) test kit (Pierce Biotechnology, Inc., Rockford, IL, USA) to determine whether these cytokines could be used as markers of enhanced periprosthetic osteolysis, leading to aseptic loosening of total/partial hip arthroplasty or revision surgery. Synovial fluid was harvested from 23 patients undergoing primary total hip arthroplasty and 35 patients undergoing total/partial hip revision due to aseptic loosening. In the revision group, four cases had suffered a prosthesis fracture and five were second revisions. ILs 6 and 8 were significantly higher in the revisions (305 and 817 pg/mL) compared with the primary arthroplasties (151 and 151 pg/mL), including cases with prosthesis fracture and those requiring a second revision. IL-10 levels were lower (not significantly) in second revision samples compared with those of revision samples. IL-1, levels were significantly higher in prosthesis fracture samples compared with those of all the other revision samples. No statistically significant differences in IL levels were found between osteoarthritis samples and those of other diseases. These results are a step forward to elucidating the complex network of events that are involved in loosening of hip implants. [source]


Alveolar ridge augmentation with a prototype trilayer membrane and various bone grafts: a histomorphometric study in baboons

CLINICAL ORAL IMPLANTS RESEARCH, Issue 2 2005
Dieter Busenlechner
Abstract: Barrier membranes have become a standard treatment option in alveolar ridge augmentation prior to implant placement. However, non-resorbable membranes require secondary surgery and resorbable membranes show an unfavorable degradation profile. The purpose of this study was to evaluate the potential of a slowly biodegradable/bioresorbable prototype trilayer membrane (PTLM) for supporting bone regeneration in alveolar ridge augmentation. Clinically relevant cavities were made 3 months after the extraction of the first and second molars in each jaw of six baboons. Each animal was treated with four different regimens: (1) autogenous bone block (ABB) alone, (2) ABB+PTLM, (3) deproteinized bovine bone mineral (DBBM)+PTLM and (4) no treatment. After 9 months, the baboons were sacrificed and block sections of the augmented area were subjected to histologic and histomorphometric analyses. Newly formed bone areas were determined at a distance of 1, 3, 7 and 10 mm from crestal. The data showed a well-preserved ridge profile at the membrane-protected sites, whereas non-protected bone blocks and control sites underwent severe resorption resulting in knife-edge ridge profiles. Significant differences were found between ABB+PTLM and ABB (P=0.0137,0.0232). DBBM+PTLM also produced a larger bone area compared with ABB alone (P=0.0396,0.0439). No significant difference in bone area was detectable between ABB+PTLM and DBBM+PTLM (P>0.05). The present study supports the use of the slowly biodegradable/bioresorbable PTLM with autografts and DBBM for lateral ridge augmentation in this type of bone defects. Résumé Les membranes barrière sont devenues une option de traitement standard dans l'épaississement du rebord alvéolaire avant le placement des implants. Cependant, des membranes non-résorbables requièrent une seconde chirurgie et les membranes résorbables montrent un profil de dégradation peu favorable. Le but de cette étude a été d'évaluer le potentiel d'une membrane prototype de trois épaisseurs (PTLM) qui était biodégradable/biorésorbable lentement pour aider la régénération osseuse dans les épaississements de rebord alvéolaire. Des cavités cliniques ont été creusées trois mois après l'avulsion des premières et deuxièmes molaires de chaque mâchoire chez six babouins. Chaque animal a été traité de quatre manières différentes : 1) un bloc osseux autogène (ABB), 2) ABB+PTLM, 3) la partie minérale de l'os bovin déprotéiné (DBBM)+PTLM et 4) pas de traitement. Après neuf mois les babouins ont été euthanasiés et des coupes en blocs de la région épaissie ont été soumises aux analyses histologiques et histomorphométriques. Les zones d'os néoforméétaient déterminées à une distance de 1, 3, 7 et 10 mm du rebord alvéolaire. Les données ont montré un profil bien préservé au niveau des sites protégés par les membranes tandis que les blocs osseux non-protégés et les sites contrôles subissaient une résorption importante en un profil en forme de lame de couteau. Des différences significatives ont été trouvées entre ABB+PTLM et ABB (P=0,0137 àP=0,0232). DBBM+PTLM produisait aussi une aire osseuse plus importante comparéà ABB seul (P=0,0396 àP=0,0439). Aucune différence significative dans l'aire osseuse n'était visible entre ABB+PTLM et DBBM+PTLM (P>0,05). L'étude présente prône l'utilisation de la membrane prototype en trois couches biodégradable/biorésorbable lentement avec du minéral osseux bovin déprotéiné et des autogreffes pour l'augmentation latérale du rebord alvéolaire dans ce type de lésions osseuses. Zusammenfassung Muss vor der Implantation eine Knochenkammaugmentation durchgeführt werden, so ist die GBR mit der Membrantechnik als Standardbehandlung anzuführen. Nichtresorbierbare Membranen erfordern jedoch einen chirurgischen Zweiteingriff, und resorbierbare Membranen zeigen ein ungünstiges Verhalten während der Resorptionsphase. Das Ziel dieser Studie war, bei der GBR die Platzhalterfunktion des Prototyps einer dreischichtig aufgebautenen Membran (PTLM) zu untersuchen, die langsam biologisch abgebaut und resorbiert wird. Drei Monate nach der Extraktion der ersten und zweiten Molaren in jedem Kiefer von sechs Pavianaffen präparierte man klinisch relevante Kavitäten. Jedes Tier erhielt vier verschiedene Behandlungsmodalitäten: (1) nur autologe Knochenblöcke (ABB), (2) ABB+PTLM, (3) entproteinisiertes Knochenmineral vom Rind (DBBM)+PTLM und (4) keine Behandlung. Nach 9 Monaten opferte man die Paviane, entnahm von den aufgebauten Stellen Blockbiopsien und bereitete sie für die histologischen und histomorphometrischen Analysen auf. Auf die Suche nach Regionen mit neu gebildetem Knochen ging man in 1, 3, 7 und 10 mm Entfernung vom crestalen Knochen. Die Daten zeigten bei den mit Membranen abgedeckten und geschützten Stellen ein gut erhaltenes Alveolarkammprofil. Bei den ungeschützten Knochenblöcken und den Kontrollstellen kam es zu ausgedehnten Resorptionen, es resultierten messerscharf auslaufende Kammprofile. Man fand signifikante Unterschiede zwischen ABB+PTLM und ABB (P=0.0137 zu P=0.232). Auch DBBM+PTLM brachte, verglichen mit nur ABB, eine bessere Knochenauffüllung (P=0.0396 zu P=0.0439). Zwischen den Varianten ABB+PTLM und DBBM+PTLM fanden sich im untersuchten Kochen keine signifikanten Unterschiede (P>0.05). Diese Arbeit befürwortet bei der lateralen Knochenkammaugmentation eines solchen Knochendefektes den Einsatz eines Prototyps einer dreischichtigen Membran (PTLM), die langsam biologisch abgebaut und resorbiert wird, sowie von autologen Knochentransplantaten und entproteinisiertem Knochenmineral vom Rind. Resumen Las membranas de barrera se han convertido en una opción estándar de tratamiento en aumento de la cresta alveolar previo a la colocación del implante. De todos modos, las membranas no reabsorbibles requieren de un segundo procedimiento quirúrgico y las membranas reabsorbibles muestran un perfil de degradación desfavorable. El propósito de este estudio fue evaluar el potencial de un prototipo de membrana de tres capas (PTLM) biodegradable/biorreabsorbible para apoyar la regeneración ósea en el aumento de la cresta alveolar. Se realizaron cavidades clínicamente relevantes tres meses después de la extracción del primer y segundo molares de cada mandíbula de seis babuinos. Cada animal se trató con cuatro diferentes regímenes: (1) bloque de hueso autógeno (ABB) únicamente, (2) ABB+ PTLM, (3) hueso mineral bovino desproteinizado (DBBM)+PTLM y (4) sin tratamiento. Tras 9 meses se sacrificó a los babuinos y secciones en bloque del área aumentada se sometieron a análisis histológicos e histomorfométricos. Se determinaron las áreas de hueso neoformado a una distancia de 1, 3, 7, y 10 mm de la cresta. Los datos mostraron un perfil de la cresta bien preservado en los lugares protegidos por la membrana, mientras que los bloques de hueso no protegido y los lugares de control sufrieron una severa reabsorción resultando en unos perfiles de cresta en filo de cuchillo. Se encontraron diferencias significativas entre ABB+PTLM y ABB (P=0.0137 a P=0.0232). DBBM+PTLM también produjeron unas áreas mayores de hueso comparadas con ABB únicamente (P=0.0396 a P=0.0439). No se detectaron diferencias significativas entre ABB+PTLM y DBBM+PTLM (P>0.05). El presente estudio apoya el uso del prototipo de membrana de tres capas lentamente biodegradable/biorreabsorbible con autoinjertos y hueso mineral bovino desproteinizado para aumento lateral de la cresta en este tipo de defectos. [source]